Jacobson Pharma's net profit under IFRS for fiscal 2020 was HK$219.108 million, down 15.3 percent from HK$258.678 million the previous year. Revenue increased by 6.4% to HK$1.572 billion compared to HK$1.478 billion a year earlier.
Jacobson Pharma's net profit under IFRS for fiscal 2020 was HK$219.108 million, down 15.3 percent from HK$258.678 million the previous year. Revenue increased by 6.4% to HK$1.572 billion compared to HK$1.478 billion a year earlier. 
www1.hkexnews.hk
English (US) 